Tucci, F. Et Al. 2021. Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection. HAEMATOLOGICA , vol.106, no.2 , 641-646.

Tucci, F., Galo, V., Barzaghi, ., Ferrua, F., Migliavacca, ., Calbi , V., ... Doglio, M.(2021). Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection. HAEMATOLOGICA , vol.106, no.2, 641-646.

Tucci, Francesca Et Al. "Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection," HAEMATOLOGICA , vol.106, no.2, 641-646, 2021

Tucci, Francesca Et Al. "Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection." HAEMATOLOGICA , vol.106, no.2, pp.641-646, 2021

Tucci, F. Et Al. (2021) . "Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection." HAEMATOLOGICA , vol.106, no.2, pp.641-646.

@article{article, author={Francesca Tucci Et Al. }, title={Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection}, journal={HAEMATOLOGICA}, year=2021, pages={641-646} }